HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 48186,
"recordsTotal": 48186,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=-completion_date&start=48000",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=-completion_date&start=47400",
"results": [
{
"registry_id": "NCT05605899",
"publication_url": "https://clinicaltrials.gov/study/NCT05605899",
"title": "An Adaptive Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Axicabtagene Ciloleucel Versus Standard of Care Therapy as First-Line Therapy in Subjects With High-Risk Large B-Cell Lymphoma (ZUMA-23)",
"has_exemption": false,
"start_date": "2023-02-10",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kite, A Gilead Company",
"sponsor_slug": "kite-a-gilead-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06007677",
"publication_url": "https://clinicaltrials.gov/study/NCT06007677",
"title": "A Phase 2 Long-Term Open-Label Trial to Assess the Safety and Efficacy of Repeat Dosing of STAR-0215 in Adult Patients With Hereditary Angioedema (The ALPHA-SOLAR Trial)",
"has_exemption": false,
"start_date": "2023-09-26",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astria Therapeutics, Inc.",
"sponsor_slug": "astria-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679101",
"publication_url": "https://clinicaltrials.gov/study/NCT06679101",
"title": "A Phase 3, Randomized, Open-label Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)",
"has_exemption": false,
"start_date": "2024-12-16",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06839456",
"publication_url": "https://clinicaltrials.gov/study/NCT06839456",
"title": "Phase 1/2 Study: CD45RA Depleted Peripheral Stem Cell Addback to Prevent Viral and Fungal Infections Following Alternative Donor TCRab/CD19 Depleted Hematopoietic Stem Cell Transplant",
"has_exemption": false,
"start_date": "2025-03-21",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06907875",
"publication_url": "https://clinicaltrials.gov/study/NCT06907875",
"title": "A Phase 1/2 Open-label Dose-escalation Study to Evaluate the Safety, Tolerability, and Biological Activity of EPI-321, an AAVrh74-delivered Epigenetic Editing Therapy in Adult FSHD Patients",
"has_exemption": false,
"start_date": "2025-05-08",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Epicrispr Biotechnologies, Inc.",
"sponsor_slug": "epicrispr-biotechnologies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07157774",
"publication_url": "https://clinicaltrials.gov/study/NCT07157774",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvalaplin on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) Who Have Had a Prior Atherosclerotic Cardiovascular Event or Are at Risk for a First Atherosclerotic Cardiovascular Event",
"has_exemption": false,
"start_date": "2025-09-02",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07202598",
"publication_url": "https://clinicaltrials.gov/study/NCT07202598",
"title": "A Phase 2 Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis",
"has_exemption": false,
"start_date": "2025-11-12",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07346157",
"publication_url": "https://clinicaltrials.gov/study/NCT07346157",
"title": "PNOC044: Liothyronine (L-T3) in Combination With Bevacizumab, Irinotecan and Temozolomide (BIT) for Progressive or Relapsed Medulloblastoma (Cohort 1) or as Monotherapy for Medulloblastoma With Minimal Residual Disease (Cohort 2)",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sabine Mueller, MD, PhD",
"sponsor_slug": "sabine-mueller-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04756063",
"publication_url": "https://clinicaltrials.gov/study/NCT04756063",
"title": "Parenteral Ascorbic Acid Repletion in TransplantatIon (PARTI): A Randomized, Double-Blinded, Placebo-Controlled Trial",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325487",
"publication_url": "https://clinicaltrials.gov/study/NCT07325487",
"title": "Adaptive Deep Brain Stimulation Targeting the Interposed Nucleus to Treat Spinocerebellar Ataxia",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07346209",
"publication_url": "https://clinicaltrials.gov/study/NCT07346209",
"title": "STudy of Real-world Individualized Precision-oncology",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07303816",
"publication_url": "https://clinicaltrials.gov/study/NCT07303816",
"title": "STAT-CAT: Statin Therapy to Prevent Cancer Associated Venous Thromboembolism",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07179003",
"publication_url": "https://clinicaltrials.gov/study/NCT07179003",
"title": "A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Rochester",
"sponsor_slug": "university-of-rochester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07466316",
"publication_url": "https://clinicaltrials.gov/study/NCT07466316",
"title": "A Randomized Phase 3 Study to Compare VAC (Higher Cyclophosphamide Dose and Intensity) Versus VAC/VI (Lower Cyclophosphamide Dose and Intensity) Plus Maintenance Therapy in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma",
"has_exemption": false,
"start_date": "2026-06-22",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04387305",
"publication_url": "https://clinicaltrials.gov/study/NCT04387305",
"title": "Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children (TIC-TOC): An Efficacy Study",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Daniel Nishijima, MD, MAS",
"sponsor_slug": "daniel-nishijima-md-mas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06785415",
"publication_url": "https://clinicaltrials.gov/study/NCT06785415",
"title": "Phase 1/2 Trial of Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for Relapsed Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-03-18",
"completion_date": "2031-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07321912",
"publication_url": "https://clinicaltrials.gov/study/NCT07321912",
"title": "A Phase II Open Label Basket Trial Study Using Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2031-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07392580",
"publication_url": "https://clinicaltrials.gov/study/NCT07392580",
"title": "A Single-Arm, Open-Label Study of Intralesional Treatment of Laryngeal Squamous Cell Carcinoma With Cisplatin",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2031-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07468903",
"publication_url": "https://clinicaltrials.gov/study/NCT07468903",
"title": "Phase II Trial of Focal Radiation Therapy in Patients With Prostate Cancer",
"has_exemption": false,
"start_date": "2026-04-04",
"completion_date": "2031-04-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227454",
"publication_url": "https://clinicaltrials.gov/study/NCT07227454",
"title": "A Double-blind, Randomized, Psychoactive Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine 84 mg in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder in Adolescent Participants With Acute Suicidal Ideation or Behavior",
"has_exemption": false,
"start_date": "2026-01-08",
"completion_date": "2031-04-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05367440",
"publication_url": "https://clinicaltrials.gov/study/NCT05367440",
"title": "A Multi-arm, Open-label Phase I/IIa Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of AZD5305 in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer (PETRANHA)",
"has_exemption": false,
"start_date": "2022-06-02",
"completion_date": "2031-04-11",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06408259",
"publication_url": "https://clinicaltrials.gov/study/NCT06408259",
"title": "A Phase 3, Multicenter, Double-blind, Active-controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Ozanimod Compared to Oral Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis",
"has_exemption": false,
"start_date": "2025-04-08",
"completion_date": "2031-04-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05788536",
"publication_url": "https://clinicaltrials.gov/study/NCT05788536",
"title": "A PHASE 1/2, OPEN-LABEL, MULTICENTER TRIAL WITH A SINGLE ASCENDING DOSE COHORT WITH UNILATERAL INTRACOCHLEAR INJECTION FOLLOWED BY A BILATERAL INJECTION EXPANSION COHORT TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF DB-OTO IN CHILDREN AND INFANTS WITH BIALLELIC hOTOF MUTATIONS",
"has_exemption": false,
"start_date": "2023-06-27",
"completion_date": "2031-04-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06912698",
"publication_url": "https://clinicaltrials.gov/study/NCT06912698",
"title": "A Phase III Randomized Controlled Non-Inferiority Clinical Trial Comparing Reduced-Dose Versus Standard-Dose Radiotherapy Based on Treatment Response in Early-Stage Nasopharyngeal Carcinoma",
"has_exemption": false,
"start_date": "2025-05-22",
"completion_date": "2031-04-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Hai-Qiang Mai,MD,PhD",
"sponsor_slug": "hai-qiang-maimdphd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288359",
"publication_url": "https://clinicaltrials.gov/study/NCT07288359",
"title": "An Open-label, Multi-center, Phase I/II Study of GVV858 as a Single Agent and in Combination With Endocrine Therapy in Patients With Advanced Hormone Receptor Positive, HER2- Negative Breast Cancer and Other Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-12-29",
"completion_date": "2031-04-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05675410",
"publication_url": "https://clinicaltrials.gov/study/NCT05675410",
"title": "A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2023-05-11",
"completion_date": "2031-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01958086",
"publication_url": "https://clinicaltrials.gov/study/NCT01958086",
"title": "Visuomotor Prosthetic for Paralysis",
"has_exemption": false,
"start_date": "2013-10-01",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Richard A. Andersen, PhD",
"sponsor_slug": "richard-a-andersen-phd",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05552222",
"publication_url": "https://clinicaltrials.gov/study/NCT05552222",
"title": "A Phase 3 Randomized Study Comparing Teclistamab in Combination With Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab SC and Lenalidomide (Tal-DR) Versus Daratumumab SC, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma Who Are Either Ineligible or Not Intended for Autologous Stem Cell Transplant as Initial Therapy",
"has_exemption": false,
"start_date": "2022-10-25",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06799195",
"publication_url": "https://clinicaltrials.gov/study/NCT06799195",
"title": "A Phase II Randomized Trial to Optimize GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation in Older Adults With Hematological Malignancies: the PROMISE Trial",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Nebraska",
"sponsor_slug": "university-of-nebraska",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07387549",
"publication_url": "https://clinicaltrials.gov/study/NCT07387549",
"title": "A Phase III, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis",
"has_exemption": false,
"start_date": "2026-04-14",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227285",
"publication_url": "https://clinicaltrials.gov/study/NCT07227285",
"title": "Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene Therapy Expressing a Transgene Encoding the Light Chain of Botulinum Toxin F",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "EG 427",
"sponsor_slug": "eg-427",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07472322",
"publication_url": "https://clinicaltrials.gov/study/NCT07472322",
"title": "UW26001 Phase I/II Study on the Safety, Tolerability, and Preliminary Efficacy of ASTX727 (Decitabine/Cedazuridine) and Retifanlimab-dlwr in Patients With Advanced Merkel Cell Carcinoma Who Have Progressed on Anti-PD-(L)1 Inhibitor",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07021937",
"publication_url": "https://clinicaltrials.gov/study/NCT07021937",
"title": "Investigating Brain PLASTICity and GLP-1 Receptor Agonists in the Treatment of Obesity: The PLASTIC Trial",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07332182",
"publication_url": "https://clinicaltrials.gov/study/NCT07332182",
"title": "Multicenter Prospective Randomized Study of MaioRegenTM Prime vs. Debridement (Surgical Standard of Care (SSOC)) for the Treatment of Osteochondral Lesion of the Knee Joint - OSTEOCONFIRM Study",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Fin-Ceramica Faenza Spa",
"sponsor_slug": "fin-ceramica-faenza-spa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06964230",
"publication_url": "https://clinicaltrials.gov/study/NCT06964230",
"title": "A Phase 2b/3 Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-10-26",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "T3D Therapeutics, Inc.",
"sponsor_slug": "t3d-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05991388",
"publication_url": "https://clinicaltrials.gov/study/NCT05991388",
"title": "A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2024-05-02",
"completion_date": "2031-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Birmingham",
"sponsor_slug": "university-of-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07457385",
"publication_url": "https://clinicaltrials.gov/study/NCT07457385",
"title": "Congenital Syphilis Treatment Trial (CONSISTENT): Phase IV, Open-label, Randomized Controlled Trial of Amoxicillin vs. Benzathine in Neonates With Possible Congenital Syphilis",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2031-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05253131",
"publication_url": "https://clinicaltrials.gov/study/NCT05253131",
"title": "Phase 1/2 Trial of the MEK Inhibitor Selumetinib and Bromodomain Inhibitor ZEN-3694 With Durvalumab (MEDI4736), a PD-L1 Antibody for Sarcomas Including Malignant Peripheral Nerve Sheath Tumors",
"has_exemption": false,
"start_date": "2026-05-15",
"completion_date": "2031-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03033992",
"publication_url": "https://clinicaltrials.gov/study/NCT03033992",
"title": "Feasibility Trial of Optune for Children With Recurrent or Progressive Supratentorial High-Grade Glioma or Ependymoma, and Feasibility and Efficacy Trial of Optune in Conjunction With Radiation Therapy for Children With Newly Diagnosed DIPG",
"has_exemption": false,
"start_date": "2017-04-04",
"completion_date": "2031-05-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06710626",
"publication_url": "https://clinicaltrials.gov/study/NCT06710626",
"title": "CONVOY: An Early Feasibility Study of Neural Control of Assistive Devices Via Brain-Computer Interface Technology",
"has_exemption": false,
"start_date": "2024-11-25",
"completion_date": "2031-05-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Neuralink Corp",
"sponsor_slug": "neuralink-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07444489",
"publication_url": "https://clinicaltrials.gov/study/NCT07444489",
"title": "An Open-Label Long-Term Extension Study for Participants From the 299AR301 Felzartamab Study",
"has_exemption": false,
"start_date": "2026-03-10",
"completion_date": "2031-05-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05561387",
"publication_url": "https://clinicaltrials.gov/study/NCT05561387",
"title": "A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of \"Intermediate Fit\" Comparing Upfront Three-Drug Induction Regimens Followed by Double or Single-Agent Maintenance",
"has_exemption": false,
"start_date": "2023-10-12",
"completion_date": "2031-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06078709",
"publication_url": "https://clinicaltrials.gov/study/NCT06078709",
"title": "Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal/Gastroesophageal Junction Adenocarcinoma (PHOX)",
"has_exemption": false,
"start_date": "2023-11-20",
"completion_date": "2031-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06919003",
"publication_url": "https://clinicaltrials.gov/study/NCT06919003",
"title": "Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (RTB-021)",
"has_exemption": false,
"start_date": "2025-09-22",
"completion_date": "2031-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03314181",
"publication_url": "https://clinicaltrials.gov/study/NCT03314181",
"title": "A Phase 1/2, Multicenter, Dose-Escalation and Expansion Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Subjects With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2018-04-02",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04923958",
"publication_url": "https://clinicaltrials.gov/study/NCT04923958",
"title": "Rapid Research in Diagnostics Development for TB Network (R2D2 TB Network) Study",
"has_exemption": false,
"start_date": "2021-04-14",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05856370",
"publication_url": "https://clinicaltrials.gov/study/NCT05856370",
"title": "The Ailliance Post-Market Clinical Study: All enablIng technoLogies, bioLogics, IDS, And Core spiNe produCt collEction",
"has_exemption": false,
"start_date": "2023-05-01",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Spinal and Biologics",
"sponsor_slug": "medtronic-spinal-and-biologics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07462507",
"publication_url": "https://clinicaltrials.gov/study/NCT07462507",
"title": "Investigation of Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07278362",
"publication_url": "https://clinicaltrials.gov/study/NCT07278362",
"title": "Safety of Intramuscular Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07428148",
"publication_url": "https://clinicaltrials.gov/study/NCT07428148",
"title": "Phase I/II Trial of Induction Lattice-Based Radiotherapy and Chemoimmunotherapy Preceding Response-Adapted Definitive Chemoradiation for Non-Low Risk Oropharyngeal Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07479797",
"publication_url": "https://clinicaltrials.gov/study/NCT07479797",
"title": "A Phase 3, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kite, A Gilead Company",
"sponsor_slug": "kite-a-gilead-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07167953",
"publication_url": "https://clinicaltrials.gov/study/NCT07167953",
"title": "MRI Technology for Greater Efficiency and Improved Value",
"has_exemption": false,
"start_date": "2028-08-31",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02375204",
"publication_url": "https://clinicaltrials.gov/study/NCT02375204",
"title": "A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) with High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) As First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors",
"has_exemption": false,
"start_date": "2015-08-06",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06967610",
"publication_url": "https://clinicaltrials.gov/study/NCT06967610",
"title": "Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Time-limited Treatment for Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07158567",
"publication_url": "https://clinicaltrials.gov/study/NCT07158567",
"title": "Veterans' Intervention Blending NeuRomodulation and YogA for Chronic Low Back PaiN Treatment: VIBRANT",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07415772",
"publication_url": "https://clinicaltrials.gov/study/NCT07415772",
"title": "The Effect of Right dlPFC cTBS on Acute Measures of Anxiety, Functional Connectivity, and TMS-evoked BOLD Responses.",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04007276",
"publication_url": "https://clinicaltrials.gov/study/NCT04007276",
"title": "The Effect of Lumify™ (Brimonidine Tartrate Ophthalmic Solution 0.025%) on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients Using Brimonidine 0.2%, 0.15%, or 0.1%",
"has_exemption": false,
"start_date": "2026-11-10",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Tulane University",
"sponsor_slug": "tulane-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06351592",
"publication_url": "https://clinicaltrials.gov/study/NCT06351592",
"title": "First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ALN-SOD in Participants With Amyotrophic Lateral Sclerosis and SOD1 Mutations",
"has_exemption": false,
"start_date": "2024-08-28",
"completion_date": "2031-06-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04657822",
"publication_url": "https://clinicaltrials.gov/study/NCT04657822",
"title": "An Open-label, Multi-center, Phase IV, Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study",
"has_exemption": false,
"start_date": "2021-06-10",
"completion_date": "2031-06-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222553",
"publication_url": "https://clinicaltrials.gov/study/NCT07222553",
"title": "Open-label, Uncontrolled, Multicenter Trial to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Children From 2 Years to Less Than 18 Years of Age With Immunoglobulin G4-related Disease (IgG4-RD)",
"has_exemption": false,
"start_date": "2026-04-03",
"completion_date": "2031-06-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05769777",
"publication_url": "https://clinicaltrials.gov/study/NCT05769777",
"title": "An Open-Label Multinational, Multicenter Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis",
"has_exemption": false,
"start_date": "2023-04-03",
"completion_date": "2031-06-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02065011",
"publication_url": "https://clinicaltrials.gov/study/NCT02065011",
"title": "An Open-label Study to Determine the Long-term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B",
"has_exemption": false,
"start_date": "2013-09-12",
"completion_date": "2031-06-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06482684",
"publication_url": "https://clinicaltrials.gov/study/NCT06482684",
"title": "Early Treatment Intensification in Patients With High Risk Mantle Cell Lymphoma Using CAR-T-cell Treatment After an Abbreviated Induction Therapy With Rituximab and Ibrutinib and 6 Months Ibrutinib Maintenance (Arm A) as Compared to Standard of Care Induction and Maintenance (Arm B)",
"has_exemption": false,
"start_date": "2024-02-15",
"completion_date": "2031-06-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Christian Schmidt, MD",
"sponsor_slug": "christian-schmidt-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05805826",
"publication_url": "https://clinicaltrials.gov/study/NCT05805826",
"title": "A PHASE 1/2 RANDOMIZED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND IMMUNOPERSISTENCE OF A CLOSTRIDIOIDES DIFFICILE VACCINE ADMINISTERED WITH NOVEL ADJUVANTS IN HEALTHY ADULTS",
"has_exemption": false,
"start_date": "2023-03-23",
"completion_date": "2031-06-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06363994",
"publication_url": "https://clinicaltrials.gov/study/NCT06363994",
"title": "A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase 3 Study of Orelabrutinib in Combination with Rituximab and Bendamustine (BR) Vs. BR in Subjects with Treatment-Naїve Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-05-29",
"completion_date": "2031-06-25",
"has_results": false,
"results_due": false,
"sponsor_name": "InnoCare Pharma Inc.",
"sponsor_slug": "innocare-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06858319",
"publication_url": "https://clinicaltrials.gov/study/NCT06858319",
"title": "A Multicenter Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Zigakibart in Adults With Primary IgA Nephropathy.",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2031-06-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06134375",
"publication_url": "https://clinicaltrials.gov/study/NCT06134375",
"title": "Novel Targeting of the Microenvironment to Decrease Metastatic Recurrence of High-Risk TNBC: A Randomized Phase II Study of Tetrathiomolybdate (TM) Plus Capecitabine in Patients With Breast Cancer at High Risk of Recurrence",
"has_exemption": false,
"start_date": "2024-11-26",
"completion_date": "2031-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Dartmouth-Hitchcock Medical Center",
"sponsor_slug": "dartmouth-hitchcock-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03424018",
"publication_url": "https://clinicaltrials.gov/study/NCT03424018",
"title": "A Phase 3, Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children With Achondroplasia",
"has_exemption": false,
"start_date": "2017-12-12",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BioMarin Pharmaceutical",
"sponsor_slug": "biomarin-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04923126",
"publication_url": "https://clinicaltrials.gov/study/NCT04923126",
"title": "SJ901: Phase 1/2 Evaluation of Single Agent Mirdametinib (PD-0325901), a Brain-Penetrant MEK1/2 Inhibitor, for the Treatment of Children, Adolescents, and Young Adults With Low-Grade Glioma",
"has_exemption": false,
"start_date": "2021-06-21",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05606614",
"publication_url": "https://clinicaltrials.gov/study/NCT05606614",
"title": "An Open-label Phase 1/2/3 Study Consisting of a Phase 1/2 Safety and Dose-escalation and Phase 3 Dose-expansion Study to Evaluate Safety and Efficacy of a Single Intrathecal Administration of TSHA-102, an AAV9-Delivered Gene Therapy in Females With Rett Syndrome",
"has_exemption": false,
"start_date": "2023-03-06",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Taysha Gene Therapies, Inc.",
"sponsor_slug": "taysha-gene-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06278870",
"publication_url": "https://clinicaltrials.gov/study/NCT06278870",
"title": "Disitamab Vedotin in Combination With Pyrotinib Versus THP in the First-line Treatment for HER2-positive Advanced Breast Cancer, a Multicentre, Randomized, Double-blind Controlled, Phase III Trial",
"has_exemption": false,
"start_date": "2023-09-06",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University",
"sponsor_slug": "sun-yat-sen-memorial-hospital-of-sun-yat-sen-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07204938",
"publication_url": "https://clinicaltrials.gov/study/NCT07204938",
"title": "A Phase 3 Trial to Evaluate the Long-Term Safety and Efficacy of Navenibart in Participants With Hereditary Angioedema - ORBIT-EXPANSE",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Astria Therapeutics, Inc.",
"sponsor_slug": "astria-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07480564",
"publication_url": "https://clinicaltrials.gov/study/NCT07480564",
"title": "ASPIRE Study: A Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Administration of TSHA-102, an AAV9-Delivered Gene Therapy, for the Treatment of Pediatric Females Aged >2 to <4 Years With Rett Syndrome",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Taysha Gene Therapies, Inc.",
"sponsor_slug": "taysha-gene-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06639607",
"publication_url": "https://clinicaltrials.gov/study/NCT06639607",
"title": "Phase 1/2 Trial of PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma (PRiME II)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07138274",
"publication_url": "https://clinicaltrials.gov/study/NCT07138274",
"title": "A Phase II, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Metyrapone in Subjects Diagnosed With Mild Autonomous Cortisol Secretion (MACS)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325149",
"publication_url": "https://clinicaltrials.gov/study/NCT07325149",
"title": "Exoskeletal-assisted Walking Combined With Transcutaneous Spinal Cord Stimulation: Effect on Imaging and Serum Biomarkers of Skeletal Muscle Mass and Bone Strength.",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bronx VA Medical Center",
"sponsor_slug": "bronx-va-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06052956",
"publication_url": "https://clinicaltrials.gov/study/NCT06052956",
"title": "A Phase 2 Study to Assess Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses",
"has_exemption": false,
"start_date": "2026-07-15",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Rochester",
"sponsor_slug": "university-of-rochester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07329153",
"publication_url": "https://clinicaltrials.gov/study/NCT07329153",
"title": "Neuronavigated and Non-Neuronavigated Accelerated Intermittent Theta-Burst Stimulation for Treatment-Resistant Depression A Sham-Controlled Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07449299",
"publication_url": "https://clinicaltrials.gov/study/NCT07449299",
"title": "Rct Assessing Pregnancy - Piroxicam for Ec With Levonorgestrel",
"has_exemption": false,
"start_date": "2027-03-31",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06545695",
"publication_url": "https://clinicaltrials.gov/study/NCT06545695",
"title": "Epidermal Growth Factor Receptor Inhibition for Keratinopathies",
"has_exemption": false,
"start_date": "2027-07-01",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04990921",
"publication_url": "https://clinicaltrials.gov/study/NCT04990921",
"title": "A Phase 2 Study of Palliative Radiation in Combination with Pembrolizumab in Subjects with Unresectable Metastatic Stage IV Breast Cancer: Twisted Pink",
"has_exemption": false,
"start_date": "2021-09-02",
"completion_date": "2031-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06544616",
"publication_url": "https://clinicaltrials.gov/study/NCT06544616",
"title": "A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study, to Assess Efficacy, Safety and Immunogenicity of JNJ-64042056, a Phosphorylated Tau Targeted Active Immunotherapy, in Participants With Preclinical Alzheimer's Disease",
"has_exemption": false,
"start_date": "2024-07-22",
"completion_date": "2031-07-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Pharmaceutica N.V., Belgium",
"sponsor_slug": "janssen-pharmaceutica-nv-belgium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07392892",
"publication_url": "https://clinicaltrials.gov/study/NCT07392892",
"title": "A PHASE 2/3 INTERVENTIONAL STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN TREATMENT-NAÏVE PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC GASTRIC, GASTROESOPHAGEAL JUNCTION, OR ESOPHAGEAL ADENOCARCINOMA",
"has_exemption": false,
"start_date": "2026-03-02",
"completion_date": "2031-07-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06538337",
"publication_url": "https://clinicaltrials.gov/study/NCT06538337",
"title": "Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers (HERA Trial)",
"has_exemption": false,
"start_date": "2024-07-24",
"completion_date": "2031-07-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03773965",
"publication_url": "https://clinicaltrials.gov/study/NCT03773965",
"title": "A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)",
"has_exemption": false,
"start_date": "2019-04-05",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05905926",
"publication_url": "https://clinicaltrials.gov/study/NCT05905926",
"title": "An Open-Label Long-Term Safety Study of Tenapanor for the Treatment of Irritable Bowel Syndrome With Constipation (IBS-C) in Pediatric Patients 6 to Less Than 18 Years Old",
"has_exemption": false,
"start_date": "2023-02-17",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ardelyx",
"sponsor_slug": "ardelyx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06789913",
"publication_url": "https://clinicaltrials.gov/study/NCT06789913",
"title": "A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation",
"has_exemption": false,
"start_date": "2025-06-13",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Relay Therapeutics, Inc.",
"sponsor_slug": "relay-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06899152",
"publication_url": "https://clinicaltrials.gov/study/NCT06899152",
"title": "HepQuant: Pilot Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer",
"has_exemption": false,
"start_date": "2025-07-16",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Montefiore Medical Center",
"sponsor_slug": "montefiore-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948786",
"publication_url": "https://clinicaltrials.gov/study/NCT06948786",
"title": "PROMOTE-FL: Pirtobrutinib and Mosunetuzumab to Enhance Treatment Efficacy for Patients With Relapsed/Refractory Follicular Lymphoma",
"has_exemption": false,
"start_date": "2025-11-17",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07128381",
"publication_url": "https://clinicaltrials.gov/study/NCT07128381",
"title": "Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)",
"has_exemption": false,
"start_date": "2026-01-02",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222137",
"publication_url": "https://clinicaltrials.gov/study/NCT07222137",
"title": "A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Baricitinib to Delay Stage 3 Type 1 Diabetes in At-risk Participants Aged ≥1 to <36 Years",
"has_exemption": false,
"start_date": "2026-01-12",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226206",
"publication_url": "https://clinicaltrials.gov/study/NCT07226206",
"title": "A Phase 2b, Single-Arm, Open-Label, Multicenter Study of the Safety of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07232069",
"publication_url": "https://clinicaltrials.gov/study/NCT07232069",
"title": "Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07174414",
"publication_url": "https://clinicaltrials.gov/study/NCT07174414",
"title": "Cilostazol for Prevention of Recurrent Stroke Trial",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06990737",
"publication_url": "https://clinicaltrials.gov/study/NCT06990737",
"title": "Phase 2 Pragmatic Trial Investigating Sentinel Lymph Node Biopsy (SLNB) Efficacy and Safety in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck",
"has_exemption": false,
"start_date": "2025-06-25",
"completion_date": "2031-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06866262",
"publication_url": "https://clinicaltrials.gov/study/NCT06866262",
"title": "Phase I/II Trial of Inulin Gel in Combination With Ipilimumab and Nivolumab in Advanced Renal Cell Carcinoma [ICON Trial]",
"has_exemption": false,
"start_date": "2025-08-15",
"completion_date": "2031-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07286149",
"publication_url": "https://clinicaltrials.gov/study/NCT07286149",
"title": "KEYMAKER-U01 Substudy 01F: A Phase 1b/2 Umbrella Study With Rolling Arms of Investigational Agents for Previously Treated Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With KRAS G12C Mutations",
"has_exemption": false,
"start_date": "2026-03-23",
"completion_date": "2031-08-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07063745",
"publication_url": "https://clinicaltrials.gov/study/NCT07063745",
"title": "A Randomized Phase 2/3 Study of BMS-986504 in Combination With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion",
"has_exemption": false,
"start_date": "2026-01-02",
"completion_date": "2031-08-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06568172",
"publication_url": "https://clinicaltrials.gov/study/NCT06568172",
"title": "Randomized Phase III Trial of Neoadjuvant Immunotherapy With Response-Adapted Treatment Versus Standard-of-Care Treatment for Resectable Stage III/IV Cutaneous Squamous Cell Carcinoma (C-PRE)",
"has_exemption": false,
"start_date": "2025-02-18",
"completion_date": "2031-08-14",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05442567",
"publication_url": "https://clinicaltrials.gov/study/NCT05442567",
"title": "A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Intravenous in Pediatric Patients With Ulcerative Colitis or Crohn's Disease",
"has_exemption": false,
"start_date": "2023-05-16",
"completion_date": "2031-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940297",
"publication_url": "https://clinicaltrials.gov/study/NCT06940297",
"title": "DART: Phase II Study of Dasatinib and Quercetin in Patients With Relapsed, Refractory Multiple Myeloma Receiving CAR-T Therapy",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2031-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07346196",
"publication_url": "https://clinicaltrials.gov/study/NCT07346196",
"title": "A Randomized Phase II Trial of Induction Cemiplimab Plus Chemotherapy With or Without Fianlimab in Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck",
"has_exemption": false,
"start_date": "2027-02-07",
"completion_date": "2031-08-22",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06922318",
"publication_url": "https://clinicaltrials.gov/study/NCT06922318",
"title": "A Phase II Study of Sequential Bipolar Androgen Therapy and ZEN-3694 in Sequence With Enzalutamide + ZEN-3694 in Asymptomatic Patients With Metastatic CRPC: The COSMYC Trial (COmbined Suppression of MYC)",
"has_exemption": false,
"start_date": "2025-08-19",
"completion_date": "2031-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228221",
"publication_url": "https://clinicaltrials.gov/study/NCT07228221",
"title": "iStent Infinite and iDose TR for Management of Moderate to Severe Primary Open Angle Glaucoma Are a Safe and Effective Alternative to Filtering Surgery for IOP Reduction in Patients With Medically Uncontrolled Glaucoma. (POAG)",
"has_exemption": false,
"start_date": "2026-01-05",
"completion_date": "2031-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonathon Myers",
"sponsor_slug": "jonathon-myers",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00969111",
"publication_url": "https://clinicaltrials.gov/study/NCT00969111",
"title": "Postoperative or Salvage Radiotherapy for Node Negative Prostate Cancer Following Radical Prostatectomy",
"has_exemption": false,
"start_date": "2009-08-31",
"completion_date": "2031-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Proton Collaborative Group",
"sponsor_slug": "proton-collaborative-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04933721",
"publication_url": "https://clinicaltrials.gov/study/NCT04933721",
"title": "An Open-label Study to Provide Berotralstat Access to Subjects With Type 1 and 2 Hereditary Angioedema Who Were Previously Enrolled in Berotralstat Studies",
"has_exemption": false,
"start_date": "2021-07-23",
"completion_date": "2031-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BioCryst Pharmaceuticals",
"sponsor_slug": "biocryst-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06790784",
"publication_url": "https://clinicaltrials.gov/study/NCT06790784",
"title": "A Randomized Clinical Trial Evaluating Combination Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of Proliferative Diabetic Retinopathy",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2031-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jaeb Center for Health Research",
"sponsor_slug": "jaeb-center-for-health-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06441006",
"publication_url": "https://clinicaltrials.gov/study/NCT06441006",
"title": "Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis (PRISM-TB)",
"has_exemption": false,
"start_date": "2025-10-03",
"completion_date": "2031-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07322146",
"publication_url": "https://clinicaltrials.gov/study/NCT07322146",
"title": "Comparing Two Durations of Antibiotic Treatment for Children Hospitalized With Common Infections",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2031-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02448173",
"publication_url": "https://clinicaltrials.gov/study/NCT02448173",
"title": "A Randomized Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2031-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vaccinogen Inc",
"sponsor_slug": "vaccinogen-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05155033",
"publication_url": "https://clinicaltrials.gov/study/NCT05155033",
"title": "Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma",
"has_exemption": false,
"start_date": "2022-08-18",
"completion_date": "2031-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06188741",
"publication_url": "https://clinicaltrials.gov/study/NCT06188741",
"title": "Phase 2 Trial of Selumetinib for the Prevention of Plexiform Neurofibroma Growth and Morbidity in Neurofibromatosis Type 1",
"has_exemption": false,
"start_date": "2025-08-27",
"completion_date": "2031-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06833073",
"publication_url": "https://clinicaltrials.gov/study/NCT06833073",
"title": "A Phase 2 Open-label Randomized Study of V940 in Combination With BCG Versus BCG Monotherapy in Participants With High-risk Non-muscle Invasive Bladder Cancer (INTerpath-011)",
"has_exemption": false,
"start_date": "2025-03-11",
"completion_date": "2031-09-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06247995",
"publication_url": "https://clinicaltrials.gov/study/NCT06247995",
"title": "A Phase I/II, Open-label, Multi-center Trial of [177Lu]Lu-NeoB in Combination With Capecitabine in Adult Patients With Gastrin Releasing Peptide Receptor Positive, Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor-2 Negative Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.",
"has_exemption": false,
"start_date": "2024-08-14",
"completion_date": "2031-09-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04929028",
"publication_url": "https://clinicaltrials.gov/study/NCT04929028",
"title": "Risk-Adapted Therapy for HIV-Associated Anal Cancer",
"has_exemption": false,
"start_date": "2022-08-09",
"completion_date": "2031-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02919592",
"publication_url": "https://clinicaltrials.gov/study/NCT02919592",
"title": "MemoryShape® and MemoryGel® Breast Implants Post Approval New Enrollment Study (\"Glow Study\")",
"has_exemption": false,
"start_date": "2016-09-01",
"completion_date": "2031-09-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Mentor Worldwide, LLC",
"sponsor_slug": "mentor-worldwide-llc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04245839",
"publication_url": "https://clinicaltrials.gov/study/NCT04245839",
"title": "A Phase 2, Open-label, Single Arm, Multicohort, Multicenter Trial to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)",
"has_exemption": false,
"start_date": "2020-07-14",
"completion_date": "2031-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06158854",
"publication_url": "https://clinicaltrials.gov/study/NCT06158854",
"title": "An Open-Label Phase 1/2 Study Evaluating the Safety and Efficacy of Etentamig (ABBV-383) in AL Amyloidosis",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2031-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07153796",
"publication_url": "https://clinicaltrials.gov/study/NCT07153796",
"title": "A Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2031-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07164469",
"publication_url": "https://clinicaltrials.gov/study/NCT07164469",
"title": "Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2031-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285239",
"publication_url": "https://clinicaltrials.gov/study/NCT07285239",
"title": "Randomized Phase 3 Trial of Belantamab Mafodotin or Daratumumab in Combination With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2031-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "PrECOG, LLC.",
"sponsor_slug": "precog-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07283679",
"publication_url": "https://clinicaltrials.gov/study/NCT07283679",
"title": "Phase I/II Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2031-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07321899",
"publication_url": "https://clinicaltrials.gov/study/NCT07321899",
"title": "Transcatheter Tricuspid Valve Replacement Using the Medtronic Intrepid™ TTVR System in Patients With Severe Symptomatic Tricuspid Regurgitation - PATHFINDER",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2031-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Cardiovascular",
"sponsor_slug": "medtronic-cardiovascular",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07178912",
"publication_url": "https://clinicaltrials.gov/study/NCT07178912",
"title": "Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)",
"has_exemption": false,
"start_date": "2026-08-27",
"completion_date": "2031-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214896",
"publication_url": "https://clinicaltrials.gov/study/NCT07214896",
"title": "HEALTH: Humanoid Evaluation and Learning Trial in Coalition-Aligned Healthcare Settings",
"has_exemption": false,
"start_date": "2025-10-06",
"completion_date": "2031-10-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Truway Health, Inc.",
"sponsor_slug": "truway-health-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07361510",
"publication_url": "https://clinicaltrials.gov/study/NCT07361510",
"title": "ROSETTA Lung-202: A Randomized, Double-Blind, Phase 3 Study of Pumitamig Monotherapy Compared to Pembrolizumab as First-line Treatment in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With PD-L1 ≥ 50%.",
"has_exemption": false,
"start_date": "2026-04-09",
"completion_date": "2031-10-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05624996",
"publication_url": "https://clinicaltrials.gov/study/NCT05624996",
"title": "Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2023-07-12",
"completion_date": "2031-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "NRG Oncology",
"sponsor_slug": "nrg-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07136012",
"publication_url": "https://clinicaltrials.gov/study/NCT07136012",
"title": "A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants With Elevated Lipoprotein(a)",
"has_exemption": false,
"start_date": "2025-08-22",
"completion_date": "2031-10-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07013487",
"publication_url": "https://clinicaltrials.gov/study/NCT07013487",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Immunogenicity, and Efficacy of V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age",
"has_exemption": false,
"start_date": "2025-06-11",
"completion_date": "2031-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07049926",
"publication_url": "https://clinicaltrials.gov/study/NCT07049926",
"title": "A Phase 1b/2 Study of Immune and Targeted Combination Therapies in Participants With RCC (KEYMAKER-U03): Substudy 03C in Participants With Recurrent Disease During or After Anti-PD-(L)1 Adjuvant Therapy",
"has_exemption": false,
"start_date": "2025-07-20",
"completion_date": "2031-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216703",
"publication_url": "https://clinicaltrials.gov/study/NCT07216703",
"title": "A Phase 3, Randomized, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab With or Without Bevacizumab Compared With Standard of Care as Firstline Maintenance Treatment for Participants With Persistent, Recurrent, or Newly Diagnosed Metastatic Cervical Cancer With PD-L1 CPS Greater Than or Equal to 1 (TroFuse-036/GOG-3123/ENGOT-cx22)",
"has_exemption": false,
"start_date": "2026-01-19",
"completion_date": "2031-10-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06236438",
"publication_url": "https://clinicaltrials.gov/study/NCT06236438",
"title": "A Randomized, Phase 2/3 Study to Evaluate the Optimal Dose, Safety, and Efficacy of Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2024-04-10",
"completion_date": "2031-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06188702",
"publication_url": "https://clinicaltrials.gov/study/NCT06188702",
"title": "A Phase 1/2, Open-label, Multicenter Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Antineoplastic Activity of S095035 (MAT2A Inhibitor) as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Homozygous Deletion of MTAP",
"has_exemption": false,
"start_date": "2024-04-29",
"completion_date": "2031-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Servier Bio-Innovation LLC",
"sponsor_slug": "servier-bio-innovation-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06013423",
"publication_url": "https://clinicaltrials.gov/study/NCT06013423",
"title": "Optimized Cord Blood Transplantation for the Treatment of High-Risk Hematologic Malignancies in Adults and Pediatrics",
"has_exemption": false,
"start_date": "2024-07-23",
"completion_date": "2031-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06898450",
"publication_url": "https://clinicaltrials.gov/study/NCT06898450",
"title": "A Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of NDI-219216 in Patients With Advanced Solid Tumors With/Without Microsatellite Instability and/or Deficient Mismatch Repair",
"has_exemption": false,
"start_date": "2025-03-31",
"completion_date": "2031-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nimbus Wadjet, Inc.",
"sponsor_slug": "nimbus-wadjet-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06563895",
"publication_url": "https://clinicaltrials.gov/study/NCT06563895",
"title": "A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Acoramidis for Transthyretin Amyloidosis Prevention in the Young (ACT-EARLY Trial)",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2031-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eidos Therapeutics, a BridgeBio company",
"sponsor_slug": "eidos-therapeutics-a-bridgebio-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07110844",
"publication_url": "https://clinicaltrials.gov/study/NCT07110844",
"title": "A Phase 2 Clinical Trial of Teclistamab and Daratumumab in Previously Untreated AL Amyloidosis",
"has_exemption": false,
"start_date": "2025-11-07",
"completion_date": "2031-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Suzanne Lentzsch, MD",
"sponsor_slug": "suzanne-lentzsch-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07368998",
"publication_url": "https://clinicaltrials.gov/study/NCT07368998",
"title": "A Phase II, Randomized, Open-Label Study Evaluating Two Inavolisib Dose Levels in Combination With Fulvestrant in Participants With PIK3CA-Mutated, HR-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2026-02-18",
"completion_date": "2031-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03729817",
"publication_url": "https://clinicaltrials.gov/study/NCT03729817",
"title": "VERiTAS-2 REFRESH ICAS (REstoring Flow by REvascularization With Submaximal Angioplasty in Hemodynamic IntraCranial Atherosclerotic Stenosis)",
"has_exemption": false,
"start_date": "2027-10-31",
"completion_date": "2031-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Case Western Reserve University",
"sponsor_slug": "case-western-reserve-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07069595",
"publication_url": "https://clinicaltrials.gov/study/NCT07069595",
"title": "PREDICT-RD: Postoperative Molecular Residual Disease by ctDNA Surveillance in TNBC With Residual Disease",
"has_exemption": false,
"start_date": "2026-02-26",
"completion_date": "2031-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06934967",
"publication_url": "https://clinicaltrials.gov/study/NCT06934967",
"title": "An Open-label, Single-arm, Multicenter, Phase 3 Study to Assess Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric PNH Patients 2 to <18 Years of Age",
"has_exemption": false,
"start_date": "2025-10-28",
"completion_date": "2031-11-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214467",
"publication_url": "https://clinicaltrials.gov/study/NCT07214467",
"title": "Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder",
"has_exemption": false,
"start_date": "2025-10-24",
"completion_date": "2031-11-22",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06549595",
"publication_url": "https://clinicaltrials.gov/study/NCT06549595",
"title": "A Phase III, Multicentre, Randomised, Open-label Study to Compare the Efficacy and Safety of AZD0486 Plus Rituximab Versus Chemotherapy Plus Rituximab in Previously Untreated Participants With Follicular Lymphoma (SOUNDTRACK-F1)",
"has_exemption": false,
"start_date": "2024-08-07",
"completion_date": "2031-11-26",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05156398",
"publication_url": "https://clinicaltrials.gov/study/NCT05156398",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migraine Prevention in Children and Adolescents ≥ 6 to <18 Years of Age",
"has_exemption": false,
"start_date": "2022-02-28",
"completion_date": "2031-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05487599",
"publication_url": "https://clinicaltrials.gov/study/NCT05487599",
"title": "An Open-label, Dose-Finding, Phase 1/2 Study to Evaluate the Safety and Tolerability of a Single Intravenous Dose of LY3884961 in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)",
"has_exemption": false,
"start_date": "2022-12-20",
"completion_date": "2031-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Prevail Therapeutics",
"sponsor_slug": "prevail-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06969430",
"publication_url": "https://clinicaltrials.gov/study/NCT06969430",
"title": "A Phase 1/2, First-in-human, Multicenter, Open-label Trial Evaluating the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)",
"has_exemption": false,
"start_date": "2025-05-30",
"completion_date": "2031-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Debiopharm International SA",
"sponsor_slug": "debiopharm-international-sa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07007312",
"publication_url": "https://clinicaltrials.gov/study/NCT07007312",
"title": "Phase 3 Randomized, Double-blind, Placebo-controlled Studies Assessing Ziftomenib in Combination With Either Standard of Care Nonintensive (Venetoclax+Azacitidine) or Intensive (7+3) Therapy in Patients With Untreated NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2025-09-26",
"completion_date": "2031-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kura Oncology, Inc.",
"sponsor_slug": "kura-oncology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06813014",
"publication_url": "https://clinicaltrials.gov/study/NCT06813014",
"title": "Sitagliptin's Effects on Glucose-stimulated Insulin Secretion and Oral Glucose",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2031-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05145010",
"publication_url": "https://clinicaltrials.gov/study/NCT05145010",
"title": "Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyrosine Kinase Inhibitor, in Children With Achondroplasia: PROPEL OLE",
"has_exemption": false,
"start_date": "2021-12-06",
"completion_date": "2031-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "QED Therapeutics, a BridgeBio company",
"sponsor_slug": "qed-therapeutics-a-bridgebio-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05145309",
"publication_url": "https://clinicaltrials.gov/study/NCT05145309",
"title": "Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans",
"has_exemption": false,
"start_date": "2026-11-15",
"completion_date": "2031-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225972",
"publication_url": "https://clinicaltrials.gov/study/NCT07225972",
"title": "An Open-Label Prospective Randomized Trial of Family Donor-Derived ADV or CMV CTLs Plus Standard of Care (SOC) vs SOC Alone in Children, Adolescents and Young Adults Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) With Refractory ADV or CMV Infection/Viremia",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2031-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "New York Medical College",
"sponsor_slug": "new-york-medical-college",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07389239",
"publication_url": "https://clinicaltrials.gov/study/NCT07389239",
"title": "A Phase I/IIA Study Evaluating the Safety and Efficacy of NY-ESO-1TCR/dnTGFBRII Engineered T Cells in Combination With Decitabine in Subjects With Recurrent or Treatment Refractory Ovarian Cancer and Other Advanced Malignancies",
"has_exemption": false,
"start_date": "2026-06-23",
"completion_date": "2031-12-10",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06663332",
"publication_url": "https://clinicaltrials.gov/study/NCT06663332",
"title": "A Phase 3, Multicenter, Open-label, Basket, LTE Study to Evaluate the Safety of Guselkumab in Pediatric Participants With Crohn's Disease, Ulcerative Colitis, or Juvenile Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2024-10-29",
"completion_date": "2031-12-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06632444",
"publication_url": "https://clinicaltrials.gov/study/NCT06632444",
"title": "A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase III Trial Evaluating Long-term Efficacy and Safety of Survodutide Weekly Injections in Adult Participants With Noncirrhotic Non-alcoholic Steatohepatitis/Metabolic Dysfunction-associated Steatohepatitis (NASH/MASH) and (F2) - (F3) Stage of Liver Fibrosis",
"has_exemption": false,
"start_date": "2024-09-17",
"completion_date": "2031-12-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04580420",
"publication_url": "https://clinicaltrials.gov/study/NCT04580420",
"title": "A Phase 2 Open-Label Study to Evaluate the Safety and Efficacy of DCR-PHXC in Patients With Primary Hyperoxaluria Type 1 and Severe Renal Impairment, With or Without Dialysis",
"has_exemption": false,
"start_date": "2021-04-15",
"completion_date": "2031-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dicerna Pharmaceuticals, Inc., a Novo Nordisk company",
"sponsor_slug": "dicerna-pharmaceuticals-inc-a-novo-nordisk-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06620302",
"publication_url": "https://clinicaltrials.gov/study/NCT06620302",
"title": "DT2216 in Combination With Irinotecan for Children, Adolescents and Young Adults With Relapsed or Refractory Solid Tumors: A Phase I Study With Phase II Feasibility Cohort for Fibrolamellar Carcinoma",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2031-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01524211",
"publication_url": "https://clinicaltrials.gov/study/NCT01524211",
"title": "Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms",
"has_exemption": false,
"start_date": "2012-01-25",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01893307",
"publication_url": "https://clinicaltrials.gov/study/NCT01893307",
"title": "Phase III Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) Versus Intensity-Modulated Photon Therapy (IMRT) for the Treatment of Oropharyngeal Cancer of the Head and Neck",
"has_exemption": false,
"start_date": "2013-08-26",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02579967",
"publication_url": "https://clinicaltrials.gov/study/NCT02579967",
"title": "Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies",
"has_exemption": false,
"start_date": "2015-11-19",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03984643",
"publication_url": "https://clinicaltrials.gov/study/NCT03984643",
"title": "Algorithms for Programming DBS Systems for ET",
"has_exemption": false,
"start_date": "2019-10-01",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04586166",
"publication_url": "https://clinicaltrials.gov/study/NCT04586166",
"title": "SASS: Randomized Trial of Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for Concomitant Management of Stress Urinary Incontinence During Minimally Invasive Sacrocolpopexy",
"has_exemption": false,
"start_date": "2020-12-23",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04124341",
"publication_url": "https://clinicaltrials.gov/study/NCT04124341",
"title": "Prefrontal Cortical Stimulation (PCS) for Severe Treatment Resistant Depression",
"has_exemption": false,
"start_date": "2021-09-29",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05478304",
"publication_url": "https://clinicaltrials.gov/study/NCT05478304",
"title": "Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial",
"has_exemption": false,
"start_date": "2023-01-25",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AtriCure, Inc.",
"sponsor_slug": "atricure-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05071937",
"publication_url": "https://clinicaltrials.gov/study/NCT05071937",
"title": "Phase ll Study of a BET Inhibitor, ZEN003694, Combined With a PARP Inhibitor, Talazoparib, in Patients With Recurrent Ovarian Cancer",
"has_exemption": false,
"start_date": "2023-04-21",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexander B Olawaiye, MD",
"sponsor_slug": "alexander-b-olawaiye-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06134232",
"publication_url": "https://clinicaltrials.gov/study/NCT06134232",
"title": "An Open -Label, Multicenter Study of Subjects With Metastatic Castrate-Resistant Prostate Cancer Treated With PROVENGE ® and Boosted With A Single Infusion of Sipuleucel-T to Measure Immune Response",
"has_exemption": false,
"start_date": "2023-10-02",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dendreon",
"sponsor_slug": "dendreon",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06428721",
"publication_url": "https://clinicaltrials.gov/study/NCT06428721",
"title": "The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population",
"has_exemption": false,
"start_date": "2024-03-20",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wright State University",
"sponsor_slug": "wright-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06483100",
"publication_url": "https://clinicaltrials.gov/study/NCT06483100",
"title": "Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance",
"has_exemption": false,
"start_date": "2024-12-20",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06529809",
"publication_url": "https://clinicaltrials.gov/study/NCT06529809",
"title": "Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06390956",
"publication_url": "https://clinicaltrials.gov/study/NCT06390956",
"title": "A Phase II Study of Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma",
"has_exemption": false,
"start_date": "2025-02-20",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06951217",
"publication_url": "https://clinicaltrials.gov/study/NCT06951217",
"title": "A Multinational, Long-Term, Safety and Tolerability, Open-Label Extension Study of Subjects Who Have Participated in Avalyn Pharma Studies of Inhaled Antifibrotic Agents (AP-LTE-008 [SAIL])",
"has_exemption": false,
"start_date": "2025-04-17",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Avalyn Pharma Inc.",
"sponsor_slug": "avalyn-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07114874",
"publication_url": "https://clinicaltrials.gov/study/NCT07114874",
"title": "A Global, Phase 3, Multicenter, Open-Label Study to Assess the Long-Term Safety and Tolerability of NBI-1117568 in Adults With Schizophrenia",
"has_exemption": false,
"start_date": "2025-07-11",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocrine Biosciences",
"sponsor_slug": "neurocrine-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07070115",
"publication_url": "https://clinicaltrials.gov/study/NCT07070115",
"title": "A Prospective Study Evaluating Clinical Hiatal Hernia Outcomes Using OviTex® Reinforced Tissue Matrix",
"has_exemption": false,
"start_date": "2025-07-25",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tela Bio Inc",
"sponsor_slug": "tela-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07005102",
"publication_url": "https://clinicaltrials.gov/study/NCT07005102",
"title": "A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-08-03",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07276438",
"publication_url": "https://clinicaltrials.gov/study/NCT07276438",
"title": "MRI- or CT-Guidance and Online Adaptation With Stereotactic Radiotherapy for Prostate Cancer (MANTICORE)",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07195591",
"publication_url": "https://clinicaltrials.gov/study/NCT07195591",
"title": "Randomized Study of Resection and GammaTile® Followed by Concurrent External Beam Radiation Therapy (EBRT) and Temozolomide (TMZ) and Adjuvant TMZ Versus Standard of Care in Newly Diagnosed Glioblastoma (GBM)",
"has_exemption": false,
"start_date": "2025-12-10",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "GT Medical Technologies, Inc.",
"sponsor_slug": "gt-medical-technologies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06694454",
"publication_url": "https://clinicaltrials.gov/study/NCT06694454",
"title": "Phase I/II Study of Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2026-03-24",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07447557",
"publication_url": "https://clinicaltrials.gov/study/NCT07447557",
"title": "A Phase 1/2 Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of a Single Dose of ELP-02 Delivered Via Lumbar Intrathecal Administration in Charcot-Marie-Tooth-4J (CMT4J)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Elpida Therapeutics SPC",
"sponsor_slug": "elpida-therapeutics-spc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07001254",
"publication_url": "https://clinicaltrials.gov/study/NCT07001254",
"title": "Phase II Open-label Clinical Trial Evaluating Efficacy of Romiplostim Added to Standard of Care for Children and Young Adults With Treatment Naive and Relapsed or Refractory Severe Aplastic Anemia",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Anjali Sharathkumar",
"sponsor_slug": "anjali-sharathkumar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06745076",
"publication_url": "https://clinicaltrials.gov/study/NCT06745076",
"title": "A Multicenter Study PRECISE-HL: Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation in Advanced Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2025-03-06",
"completion_date": "2032-01-03",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06780111",
"publication_url": "https://clinicaltrials.gov/study/NCT06780111",
"title": "A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2032-01-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07022678",
"publication_url": "https://clinicaltrials.gov/study/NCT07022678",
"title": "A Randomized Double-Blinded Trial of Xylitol Dental Wipes for the Prophylaxis of Bloodstream Infections From Oral Organisms in Pediatric Patients With Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2026-08-08",
"completion_date": "2032-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06405087",
"publication_url": "https://clinicaltrials.gov/study/NCT06405087",
"title": "A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Subcutaneous in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease",
"has_exemption": false,
"start_date": "2025-10-27",
"completion_date": "2032-01-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218887",
"publication_url": "https://clinicaltrials.gov/study/NCT07218887",
"title": "A Phase 1/2, Open-Label, Multicenter, Dose Finding and Dose Expansion Study to Investigate the Safety, Tolerability, and Efficacy of ALXN2350 Gene Therapy in Adult Participants With BAG3 Mutation Associated Dilated Cardiomyopathy",
"has_exemption": false,
"start_date": "2025-10-24",
"completion_date": "2032-01-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexion Pharmaceuticals, Inc.",
"sponsor_slug": "alexion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05789082",
"publication_url": "https://clinicaltrials.gov/study/NCT05789082",
"title": "A Phase Ib/II, Open-Label, Multicenter Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Patients With Previously Untreated Advanced Or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation",
"has_exemption": false,
"start_date": "2023-06-20",
"completion_date": "2032-01-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214688",
"publication_url": "https://clinicaltrials.gov/study/NCT07214688",
"title": "A Phase 2 Study of Fludarabine and Intermediate-dose Total Body Irradiation (800 cGy) Followed by Post-transplant Cyclophosphamide in Patients Aged 18-65 Undergoing Allogeneic Stem Cell Transplant for Hematologic Malignancies",
"has_exemption": false,
"start_date": "2026-01-06",
"completion_date": "2032-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hackensack Meridian Health",
"sponsor_slug": "hackensack-meridian-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07303894",
"publication_url": "https://clinicaltrials.gov/study/NCT07303894",
"title": "Randomized, Multi-dose, Placebo-controlled Phase 2 Trial of Oral Isoquercetin to Reduce Thrombin Generation in Ovarian Cancer",
"has_exemption": false,
"start_date": "2026-01-22",
"completion_date": "2032-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06770582",
"publication_url": "https://clinicaltrials.gov/study/NCT06770582",
"title": "Randomized Phase II Trial of Pembrolizumab and Radiation vs. Radiation and Concurrent Chemotherapy for High-Grade T1 Bladder Cancer (PARRC Trial)",
"has_exemption": false,
"start_date": "2025-06-03",
"completion_date": "2032-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06686121",
"publication_url": "https://clinicaltrials.gov/study/NCT06686121",
"title": "IMProving Mobility After revasCularizaTion in Peripheral Artery Disease: The IMPACT PAD Trial",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2032-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06788912",
"publication_url": "https://clinicaltrials.gov/study/NCT06788912",
"title": "KEYMAKER-U01 Substudy 01E: A Phase 2 Umbrella Study With Rolling Arms of Investigational Agents With or Without Chemotherapy in Combination With Pembrolizumab in Treatment of Participants With Newly Diagnosed Resectable Stages II-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-03-20",
"completion_date": "2032-02-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04165070",
"publication_url": "https://clinicaltrials.gov/study/NCT04165070",
"title": "KEYMAKER-U01 Substudy 01A: A Phase 1/2, Umbrella Study With Rolling Arms of Investigational Agents With Pembrolizumab With or Without Chemotherapy in Treatment-Naive Participants With Stage IV Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2019-12-19",
"completion_date": "2032-02-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05533697",
"publication_url": "https://clinicaltrials.gov/study/NCT05533697",
"title": "Phase 1/2 Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2022-09-01",
"completion_date": "2032-02-18",
"has_results": false,
"results_due": false,
"sponsor_name": "ModernaTX, Inc.",
"sponsor_slug": "modernatx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06057402",
"publication_url": "https://clinicaltrials.gov/study/NCT06057402",
"title": "ELRANATAMAB POST TRIAL ACCESS: AN OPEN-LABEL, SINGLE-ARM STUDY FOR PARTICIPANTS WITH MULTIPLE MYELOMA CONTINUING FROM PFIZER-SPONSORED ELRANATAMAB CLINICAL STUDIES",
"has_exemption": false,
"start_date": "2023-10-03",
"completion_date": "2032-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06807281",
"publication_url": "https://clinicaltrials.gov/study/NCT06807281",
"title": "A Phase 3, Multicenter, Long-Term, Open Label Study Evaluating the Safety and Efficacy of Abrocitinib, With or Without Topical Medications Administered to Pediatric Participants Aged 2 Years and Older With Moderate-to-Severe Atopic Dermatitis",
"has_exemption": false,
"start_date": "2025-12-02",
"completion_date": "2032-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07195695",
"publication_url": "https://clinicaltrials.gov/study/NCT07195695",
"title": "Beamion LUNG-3: A Randomized, Controlled, Multi-center Trial Evaluating Zongertinib as an Adjuvant Monotherapy Compared With Standard of Care in Patients With Early-stage, Resectable Non-small Cell Lung Cancer (Stage II-IIIB) Harboring Tyrosine Kinase Domain Activating HER2 Mutations",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2032-02-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227402",
"publication_url": "https://clinicaltrials.gov/study/NCT07227402",
"title": "A Phase 3, Randomized, Open-label Study of Belzutifan + Zanzalintinib Versus Cabozantinib in Participants With Advanced RCC Who Experienced Disease Recurrence During or After Prior Adjuvant Anti-PD-1/L1 Therapy (LITESPARK-033)",
"has_exemption": false,
"start_date": "2025-11-26",
"completion_date": "2032-02-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04774718",
"publication_url": "https://clinicaltrials.gov/study/NCT04774718",
"title": "A Phase I/II, Open-Label, Multicenter, Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors for Whom Prior Treatment Has Proven to be Ineffective or for Whom There is No Satisfactory Treatment Available",
"has_exemption": false,
"start_date": "2021-09-14",
"completion_date": "2032-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06692712",
"publication_url": "https://clinicaltrials.gov/study/NCT06692712",
"title": "Intrathecal Administration of MELPIDA (AAV9/AP4M1) For Hereditary Spastic Paraplegia Type 50 (SPG50): A Phase 3, Open-Label Trial With Matched Prospective Concurrent Control Arm",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2032-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Elpida Therapeutics SPC",
"sponsor_slug": "elpida-therapeutics-spc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05143840",
"publication_url": "https://clinicaltrials.gov/study/NCT05143840",
"title": "Asciminib as Initial Therapy With Addition of Lower Dose Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia Who do Not Achieve Optimal Response or a Deep Molecular Remission (ALERT CML)",
"has_exemption": false,
"start_date": "2022-04-22",
"completion_date": "2032-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Augusta University",
"sponsor_slug": "augusta-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06073821",
"publication_url": "https://clinicaltrials.gov/study/NCT06073821",
"title": "A Phase 3, Open-Label, Randomized Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Patients With Previously Untreated Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2023-11-11",
"completion_date": "2032-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06544798",
"publication_url": "https://clinicaltrials.gov/study/NCT06544798",
"title": "Long-term Follow-up of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia",
"has_exemption": false,
"start_date": "2024-08-02",
"completion_date": "2032-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "MeiraGTx, LLC",
"sponsor_slug": "meiragtx-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06788522",
"publication_url": "https://clinicaltrials.gov/study/NCT06788522",
"title": "The Effects of Orexin Antagonism on Fear Extinction in PTSD",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2032-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06780098",
"publication_url": "https://clinicaltrials.gov/study/NCT06780098",
"title": "KEYMAKER-U01 Substudy 01I: A Phase 2, Randomized, Umbrella Study With Rolling Arms of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-05-28",
"completion_date": "2032-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06731907",
"publication_url": "https://clinicaltrials.gov/study/NCT06731907",
"title": "KEYMAKER-U01 Substudy 01G: A Phase 2, Umbrella Study With Rolling Arms of Investigational Agents in Combination With Pembrolizumab With or Without Platinum-based Chemotherapy in Treatment-Naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-03-30",
"completion_date": "2032-03-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06780085",
"publication_url": "https://clinicaltrials.gov/study/NCT06780085",
"title": "KEYMAKER-U01 Substudy 01H: A Phase 2, Randomized, Umbrella Study With Rolling Arms of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-05-13",
"completion_date": "2032-03-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07022483",
"publication_url": "https://clinicaltrials.gov/study/NCT07022483",
"title": "A Phase 3, Multicenter, Randomized, Open-label Trial of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy With or Without Radiotherapy as Adjuvant Treatment for HER2-Expressing (IHC 3+/2+) Endometrial Cancer (DESTINY-Endometrial02/ GOG-3122/ ENGOT-en30/GINECO)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2032-03-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06991556",
"publication_url": "https://clinicaltrials.gov/study/NCT06991556",
"title": "A Phase II, Randomized, Open-label, Multi-center Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)",
"has_exemption": false,
"start_date": "2025-07-07",
"completion_date": "2032-03-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03959085",
"publication_url": "https://clinicaltrials.gov/study/NCT03959085",
"title": "A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy",
"has_exemption": false,
"start_date": "2019-10-31",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06337318",
"publication_url": "https://clinicaltrials.gov/study/NCT06337318",
"title": "Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular Lymphoma",
"has_exemption": false,
"start_date": "2024-10-23",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07110246",
"publication_url": "https://clinicaltrials.gov/study/NCT07110246",
"title": "A Phase 2 De-escalation Study of Dabrafenib and Trametinib for Patients With BRAF V600 Mutant Low-Grade Gliomas",
"has_exemption": false,
"start_date": "2025-11-07",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07169279",
"publication_url": "https://clinicaltrials.gov/study/NCT07169279",
"title": "Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascending Dose Portion and a Phase 2 Open-Label Portion, to Evaluate the Safety and Efficacy of Oral Infigratinib in Infants and Young Children With Achondroplasia",
"has_exemption": false,
"start_date": "2025-11-19",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "QED Therapeutics, a BridgeBio company",
"sponsor_slug": "qed-therapeutics-a-bridgebio-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07294677",
"publication_url": "https://clinicaltrials.gov/study/NCT07294677",
"title": "CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL",
"has_exemption": false,
"start_date": "2026-03-17",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07355205",
"publication_url": "https://clinicaltrials.gov/study/NCT07355205",
"title": "A Phase II, Single-Center, Open-Label Study of First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer (FLINN)",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649747",
"publication_url": "https://clinicaltrials.gov/study/NCT06649747",
"title": "A Double-blind, Placebo-controlled, Multi-center Phase II Study of the Safety, Tolerability, Efficacy and Pharmacokinetics of Oral AFA-281 in Patients With Painful Lumbosacral Radiculopathy",
"has_exemption": false,
"start_date": "2027-04-01",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Afasci Inc",
"sponsor_slug": "afasci-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07209111",
"publication_url": "https://clinicaltrials.gov/study/NCT07209111",
"title": "A Phase 2, Open-Label, Multicenter, Tumor-agnostic Study of MK-1084 as Monotherapy and in Combination With Cetuximab, in Participants With KRAS G12C-Mutant, Advanced Solid Tumors (KANDLELIT-014)",
"has_exemption": false,
"start_date": "2025-12-04",
"completion_date": "2032-04-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05714085",
"publication_url": "https://clinicaltrials.gov/study/NCT05714085",
"title": "A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Systemic Left Ventricular Systolic Dysfunction (VALOR)",
"has_exemption": false,
"start_date": "2023-05-31",
"completion_date": "2032-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06666322",
"publication_url": "https://clinicaltrials.gov/study/NCT06666322",
"title": "Platform Trial For Cryptococcal Meningitis",
"has_exemption": false,
"start_date": "2025-05-28",
"completion_date": "2032-04-21",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04077099",
"publication_url": "https://clinicaltrials.gov/study/NCT04077099",
"title": "A Phase 1/2 Study of REGN5093 in Patients With MET-Altered Advanced Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2020-01-07",
"completion_date": "2032-04-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04114136",
"publication_url": "https://clinicaltrials.gov/study/NCT04114136",
"title": "A Phase II Clinical Trial of Anti-PD-1 mAb Therapy Alone or With Metabolic Modulators to Reverse Tumor Hypoxia and Immune Dysfunction in Solid Tumor Malignancies",
"has_exemption": false,
"start_date": "2020-09-14",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dan Zandberg",
"sponsor_slug": "dan-zandberg",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04093349",
"publication_url": "https://clinicaltrials.gov/study/NCT04093349",
"title": "Phase 1/2, Dose-escalation Study to Evaluate the Safety, Tolerability and Efficacy of a Single Intravenous Infusion of SPK-3006 in Adults With Late-onset Pompe Disease",
"has_exemption": false,
"start_date": "2020-10-01",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Spark Therapeutics, Inc.",
"sponsor_slug": "spark-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05031897",
"publication_url": "https://clinicaltrials.gov/study/NCT05031897",
"title": "A 2 Step Approach to Haploidentical Transplant Using Radiation-Based Reduced Intensity Conditioning",
"has_exemption": false,
"start_date": "2021-10-25",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Thomas Jefferson University",
"sponsor_slug": "thomas-jefferson-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05707949",
"publication_url": "https://clinicaltrials.gov/study/NCT05707949",
"title": "A Multicenter, Open-label, Extension Study to Evaluate the Long-term Safety and Tolerability of Atogepant in Pediatric Subjects 6 to 17 Years of Age With Migraine",
"has_exemption": false,
"start_date": "2023-06-05",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05833763",
"publication_url": "https://clinicaltrials.gov/study/NCT05833763",
"title": "An Open-label, Single-arm, Phase 2 Trial of GlOfitamab anD pIrtobrutinib (LOXo-305) in Patients With Mantle Cell Lymphoma and Prior Exposure to a BTK Inhibitor",
"has_exemption": false,
"start_date": "2023-10-12",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Australasian Leukaemia and Lymphoma Group",
"sponsor_slug": "australasian-leukaemia-and-lymphoma-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05212246",
"publication_url": "https://clinicaltrials.gov/study/NCT05212246",
"title": "CSP #2019 - Basal Cell Carcinoma Chemoprevention Trial (B3C)",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2032-05-03",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07448610",
"publication_url": "https://clinicaltrials.gov/study/NCT07448610",
"title": "Onasemnogene Abeparvovec: ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2032-05-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06140524",
"publication_url": "https://clinicaltrials.gov/study/NCT06140524",
"title": "Phase 2 Dose-Ranging and Interception Study of Linvoseltamab in Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-09-16",
"completion_date": "2032-05-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06952504",
"publication_url": "https://clinicaltrials.gov/study/NCT06952504",
"title": "A Phase 3 Randomized, Open-label, Multicenter Study to Compare the Efficacy and Safety of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone as First-line Maintenance Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (TroFuse-033/GOG-3119/ENGOT-en29)",
"has_exemption": false,
"start_date": "2025-05-22",
"completion_date": "2032-05-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06790693",
"publication_url": "https://clinicaltrials.gov/study/NCT06790693",
"title": "A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib Plus a CDK4/6 Inhibitor and Letrozole Versus Placebo Plus a CDK4/6 Inhibitor and Letrozole in Patients With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer",
"has_exemption": false,
"start_date": "2025-04-09",
"completion_date": "2032-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04130997",
"publication_url": "https://clinicaltrials.gov/study/NCT04130997",
"title": "An Open Label Extension Study of Ublituximab in Subjects With Relapsing Multiple Sclerosis",
"has_exemption": false,
"start_date": "2019-11-18",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "TG Therapeutics, Inc.",
"sponsor_slug": "tg-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05630053",
"publication_url": "https://clinicaltrials.gov/study/NCT05630053",
"title": "Randomized Controlled Trial to Compare Persona OsseoTi Keel Cementless TKA vs Persona Keel Cemented TKA",
"has_exemption": false,
"start_date": "2023-07-25",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06374459",
"publication_url": "https://clinicaltrials.gov/study/NCT06374459",
"title": "A Phase Ib/II Trial of Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis",
"has_exemption": false,
"start_date": "2025-01-30",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06773910",
"publication_url": "https://clinicaltrials.gov/study/NCT06773910",
"title": "An Open-label, Randomized Study of BMS-986489 (Atigotatug + Nivolumab Fixed-dose Combination) vs Durvalumab as Consolidation Therapy Following Chemoradiotherapy in Limited-stage Small-cell Lung Cancer (TIGOS-LS)",
"has_exemption": false,
"start_date": "2025-03-11",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SCRI Development Innovations, LLC",
"sponsor_slug": "scri-development-innovations-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07005154",
"publication_url": "https://clinicaltrials.gov/study/NCT07005154",
"title": "A Phase 2, Open-label, Multi-cohort Study to Assess the Efficacy and Safety of ASP5541 in Participants With Advanced Prostate Cancer",
"has_exemption": false,
"start_date": "2025-06-19",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05947851",
"publication_url": "https://clinicaltrials.gov/study/NCT05947851",
"title": "A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Nemtabrutinib (MK-1026) Plus Venetoclax Versus Venetoclax Plus Rituximab in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Following at Least 1 Prior Therapy (BELLWAVE-010)",
"has_exemption": false,
"start_date": "2023-08-08",
"completion_date": "2032-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07190300",
"publication_url": "https://clinicaltrials.gov/study/NCT07190300",
"title": "TulmiSTAR-02: A Two-part Phase I Dose Escalation Study of Tulmimetostat (DZR123) in Combination With Darolutamide or Abiraterone Followed by Open-label, Randomized, Phase II Dose Expansion Study to Assess the Safety and Efficacy of Tulmimetostat in Combination With Darolutamide Versus Darolutamide Alone in Patients With Metastatic Hormone-sensitive Prostate Cancer",
"has_exemption": false,
"start_date": "2026-01-13",
"completion_date": "2032-06-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05468359",
"publication_url": "https://clinicaltrials.gov/study/NCT05468359",
"title": "ANGIO-A: Safety and Tolerability of Oral Cyclophosphamide and Sorafenib With Intravenous Bevacizumab With the Addition of Atezolizumab in Pediatric Solid Tumor Patients",
"has_exemption": false,
"start_date": "2022-11-07",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05425615",
"publication_url": "https://clinicaltrials.gov/study/NCT05425615",
"title": "Probing Language Processes Using Transcranial Magnetic Stimulation",
"has_exemption": false,
"start_date": "2024-06-05",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06494501",
"publication_url": "https://clinicaltrials.gov/study/NCT06494501",
"title": "The Prevent Coronary Artery Disease Trial",
"has_exemption": false,
"start_date": "2024-09-12",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940739",
"publication_url": "https://clinicaltrials.gov/study/NCT06940739",
"title": "A Phase 1/2, Open-label Study of a Modified Interleukin-2 Fusion Protein (IOV-3001) in Participants With Previously Treated, Unresectable or Metastatic Melanoma Who Will Receive Lifileucel",
"has_exemption": false,
"start_date": "2025-03-11",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Iovance Biotherapeutics, Inc.",
"sponsor_slug": "iovance-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06445114",
"publication_url": "https://clinicaltrials.gov/study/NCT06445114",
"title": "ULTRA-HPV Using Circulating Tumor DNA to Risk Adapt Post-operative Therapy for HPV Associated Oropharyngeal Cancer",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Zachary Zumsteg",
"sponsor_slug": "zachary-zumsteg",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07389278",
"publication_url": "https://clinicaltrials.gov/study/NCT07389278",
"title": "A Phase 1/2 Study of Pegylated Arginine Deiminase (ADI-PEG 20) Plus Radiotherapy (RT) and Temozolomide (TMZ) in Children, Adolescents, and Young Adults With Newly Diagnosed High-grade Glioma (HGG)",
"has_exemption": false,
"start_date": "2026-03-09",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sabine Mueller, MD, PhD",
"sponsor_slug": "sabine-mueller-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06122974",
"publication_url": "https://clinicaltrials.gov/study/NCT06122974",
"title": "A RanDomized Controlled Trial of the Drug Eluting TEmporary Spur StEnt System vs PERcutaneous Balloon Angioplasty for the TReatment of CriTical Limb Ischemia",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ReFlow Medical, Inc.",
"sponsor_slug": "reflow-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06900998",
"publication_url": "https://clinicaltrials.gov/study/NCT06900998",
"title": "A Pilot Study on the Effects of Nimodipine on Alcohol Drinking Among Adults Who Are Heavy Alcohol Drinkers",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06087263",
"publication_url": "https://clinicaltrials.gov/study/NCT06087263",
"title": "Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.",
"has_exemption": false,
"start_date": "2024-06-18",
"completion_date": "2032-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06991738",
"publication_url": "https://clinicaltrials.gov/study/NCT06991738",
"title": "Phase 1/2, Open-Label Study of the Safety, Dosimetry and Efficacy of a 3-Dose Regimen of Escalating Doses of 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer",
"has_exemption": false,
"start_date": "2026-03-24",
"completion_date": "2032-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07026942",
"publication_url": "https://clinicaltrials.gov/study/NCT07026942",
"title": "A Phase I/II Clinical Trial Evaluating the Safety and Efficacy of Universal Donor CD33 CAR Natural Killer Cells for Treatment of Relapsed/Refractory Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2032-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213830",
"publication_url": "https://clinicaltrials.gov/study/NCT07213830",
"title": "An Open-label, Phase I/II First in Human, Dose Escalation, Optimisation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Participants With Locally Advanced or Metastatic Solid Tumours Who Have Progressed on or After Immune Checkpoint Inhibitor Therapies",
"has_exemption": false,
"start_date": "2026-02-06",
"completion_date": "2032-07-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07161544",
"publication_url": "https://clinicaltrials.gov/study/NCT07161544",
"title": "An Open-label, Multicenter, Two Part, Ascending Dose Followed by a Controlled Trial to Assess the Safety and Efficacy of a Subretinal Administration of AAVB-039 in Participants With Stargardt Disease (STGD1) (CELESTE)",
"has_exemption": false,
"start_date": "2025-09-29",
"completion_date": "2032-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AAVantgarde Bio Srl",
"sponsor_slug": "aavantgarde-bio-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03579901",
"publication_url": "https://clinicaltrials.gov/study/NCT03579901",
"title": "Study of the Safety and Effectiveness of the Motiva Implants® Silicone Gel-Filled Breast Implants SmoothSilk® in Subjects Who Are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction, and Revision Surgery",
"has_exemption": false,
"start_date": "2018-04-06",
"completion_date": "2032-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Motiva USA LLC",
"sponsor_slug": "motiva-usa-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05496959",
"publication_url": "https://clinicaltrials.gov/study/NCT05496959",
"title": "177-Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (Lunar)",
"has_exemption": false,
"start_date": "2022-09-02",
"completion_date": "2032-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06991335",
"publication_url": "https://clinicaltrials.gov/study/NCT06991335",
"title": "Deep Brain Stimulation (DBS) of the Ventral Capsule Ventral Striatum (VC/VS) for the Treatment of Apathy in Parkinson's Disease (PD)",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2032-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Nora Vanegas",
"sponsor_slug": "nora-vanegas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06136559",
"publication_url": "https://clinicaltrials.gov/study/NCT06136559",
"title": "A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in Participants With Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BELLWAVE-011)",
"has_exemption": false,
"start_date": "2023-12-13",
"completion_date": "2032-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04589845",
"publication_url": "https://clinicaltrials.gov/study/NCT04589845",
"title": "Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial",
"has_exemption": false,
"start_date": "2021-01-18",
"completion_date": "2032-09-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02984761",
"publication_url": "https://clinicaltrials.gov/study/NCT02984761",
"title": "CSP #2005 - Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy Trial (VALOR)",
"has_exemption": false,
"start_date": "2017-04-13",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04687020",
"publication_url": "https://clinicaltrials.gov/study/NCT04687020",
"title": "Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)",
"has_exemption": false,
"start_date": "2021-06-10",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NS Pharma, Inc.",
"sponsor_slug": "ns-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04910685",
"publication_url": "https://clinicaltrials.gov/study/NCT04910685",
"title": "A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of BLU-263 in Indolent Systemic Mastocytosis",
"has_exemption": false,
"start_date": "2021-11-30",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Blueprint Medicines Corporation",
"sponsor_slug": "blueprint-medicines-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06574126",
"publication_url": "https://clinicaltrials.gov/study/NCT06574126",
"title": "Phase II Open-Label, Single Arm, Multicenter Study of Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma (GEM-CAR-HiRiSMM)",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "PETHEMA Foundation",
"sponsor_slug": "pethema-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05563948",
"publication_url": "https://clinicaltrials.gov/study/NCT05563948",
"title": "Repeated Administration of Cannabis Varying in THC and CBD: Effects on Abuse Liability, Experimental Pain and Plasma Endocannabinoids",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "New York State Psychiatric Institute",
"sponsor_slug": "new-york-state-psychiatric-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05460000",
"publication_url": "https://clinicaltrials.gov/study/NCT05460000",
"title": "A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy (N-Plus)",
"has_exemption": false,
"start_date": "2024-10-11",
"completion_date": "2032-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "North Eastern German Society of Gynaecological Oncology",
"sponsor_slug": "north-eastern-german-society-of-gynaecological-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06953778",
"publication_url": "https://clinicaltrials.gov/study/NCT06953778",
"title": "CSP #2037S - Veterans Affairs Learning Health System Initiative to Assess Novel Screening vs. Usual Care and Treatment With Apixaban vs. Rivaroxaban in Veterans With Atrial Fibrillation (VALIANT-AF-S) Trial",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2032-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06953726",
"publication_url": "https://clinicaltrials.gov/study/NCT06953726",
"title": "CSP #2037T - Veterans Affairs Learning Health System Initiative to Assess Novel Screening vs. Usual Care and Treatment With Apixaban vs. Rivaroxaban in Veterans With Atrial Fibrillation (VALIANT-AF-T) Trial",
"has_exemption": false,
"start_date": "2026-03-30",
"completion_date": "2032-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05521997",
"publication_url": "https://clinicaltrials.gov/study/NCT05521997",
"title": "Phase II Study of Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2032-10-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04557462",
"publication_url": "https://clinicaltrials.gov/study/NCT04557462",
"title": "A Multicenter Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan in Adult Participants With Primary IgA Nephropathy Who Have Completed Study CLNP023X2203 or CLNP023A2301",
"has_exemption": false,
"start_date": "2021-09-20",
"completion_date": "2032-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04576130",
"publication_url": "https://clinicaltrials.gov/study/NCT04576130",
"title": "A Danish Study to Assess the Efficacy of Implantable Cardioverter Defibrillator in Patients with Coronary Artery Disease Resuscitated from Ventricular Fibrillation Who Receive Complete Revascularization",
"has_exemption": false,
"start_date": "2020-10-12",
"completion_date": "2032-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rigshospitalet, Denmark",
"sponsor_slug": "rigshospitalet-denmark",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05508009",
"publication_url": "https://clinicaltrials.gov/study/NCT05508009",
"title": "Phase 1b/2a Trial of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) From an HLA-partially Matched Related or Unrelated Donor After TCRαβ+ T-cell/CD19+ B-cell Depletion for Patients Who Will Receive a Kidney Transplant (KT) From the Same HSCT/KT Donor",
"has_exemption": false,
"start_date": "2023-01-10",
"completion_date": "2032-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Alice Bertaina",
"sponsor_slug": "alice-bertaina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06235697",
"publication_url": "https://clinicaltrials.gov/study/NCT06235697",
"title": "Androgen Suppression Combined With Elective Nodal Irradiation and Dose Escalated Prostate Treatment: A Non-Inferiority, Phase III Randomized Controlled Trial of Stereotactic Body Radiation Therapy Versus Brachytherapy Boost in Patients With Unfavourable Risk Localized Prostate Cancer",
"has_exemption": false,
"start_date": "2024-04-25",
"completion_date": "2032-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Canadian Cancer Trials Group",
"sponsor_slug": "canadian-cancer-trials-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06915025",
"publication_url": "https://clinicaltrials.gov/study/NCT06915025",
"title": "A Randomized Phase 3 Trial Evaluating the Safety & Efficacy of IP IMNN-001 Administered in Combination w/ Standard Neoadjuvant & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2032-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Imunon",
"sponsor_slug": "imunon",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03897881",
"publication_url": "https://clinicaltrials.gov/study/NCT03897881",
"title": "A Phase 2 Randomized Study of Adjuvant Immunotherapy With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab Versus Pembrolizumab Alone After Complete Resection of High-Risk Melanoma (KEYNOTE- 942)",
"has_exemption": false,
"start_date": "2019-07-18",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ModernaTX, Inc.",
"sponsor_slug": "modernatx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05283720",
"publication_url": "https://clinicaltrials.gov/study/NCT05283720",
"title": "Phase 1b/2, Open-Label Study to Evaluate Safety and Tolerability of Epcoritamab in Combination With Anti-Neoplastic Agents in Subjects With Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2022-06-14",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06215716",
"publication_url": "https://clinicaltrials.gov/study/NCT06215716",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis",
"has_exemption": false,
"start_date": "2023-12-01",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akero Therapeutics, Inc",
"sponsor_slug": "akero-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06974786",
"publication_url": "https://clinicaltrials.gov/study/NCT06974786",
"title": "Frontline T-cell Engager vs Autologous Stem Cell Transplant and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma (FASTER)",
"has_exemption": false,
"start_date": "2025-08-08",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "SCRI Development Innovations, LLC",
"sponsor_slug": "scri-development-innovations-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07154550",
"publication_url": "https://clinicaltrials.gov/study/NCT07154550",
"title": "A Randomized Controlled Trial Comparing Outcomes and Complications Following Mastisol Application for Clubfoot Casting",
"has_exemption": false,
"start_date": "2026-02-11",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216235",
"publication_url": "https://clinicaltrials.gov/study/NCT07216235",
"title": "A Phase 3b/4, Multicenter, Parallel-Group, Double-Blind, Placebo Controlled, Two-Arm, Long-Term Study to Evaluate the Safety and Efficacy of Saroglitazar Magnesium on Clinical Outcomes in Participants With Primary Biliary Cholangitis (PBC)",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Zydus Therapeutics Inc.",
"sponsor_slug": "zydus-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07456865",
"publication_url": "https://clinicaltrials.gov/study/NCT07456865",
"title": "Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device",
"has_exemption": false,
"start_date": "2026-03-17",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MedtronicNeuro",
"sponsor_slug": "medtronicneuro",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07187206",
"publication_url": "https://clinicaltrials.gov/study/NCT07187206",
"title": "Safety and Efficacy of FETO in CDH Phase III",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2032-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07238452",
"publication_url": "https://clinicaltrials.gov/study/NCT07238452",
"title": "Optimising Pacing Therapy, Integrated Medical Therapy, and Catheter AbLation for Atrial Fibrillation in Heart Failure Trial",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2032-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of British Columbia",
"sponsor_slug": "university-of-british-columbia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06910124",
"publication_url": "https://clinicaltrials.gov/study/NCT06910124",
"title": "Alpe d'Huez Study: A Parallel Two-Cohort Study of Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse",
"has_exemption": false,
"start_date": "2025-12-02",
"completion_date": "2032-12-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Dickran Kazandjian, MD",
"sponsor_slug": "dickran-kazandjian-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224672",
"publication_url": "https://clinicaltrials.gov/study/NCT07224672",
"title": "A Phase 2, Open-label, Randomized, Dose Optimization Study Evaluating the Efficacy and Safety of Belantamab Mafodotin Administered in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain Amyloidosis (ALANIS)",
"has_exemption": false,
"start_date": "2026-03-20",
"completion_date": "2032-12-13",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06379789",
"publication_url": "https://clinicaltrials.gov/study/NCT06379789",
"title": "A Two-Part Open-Label Study of REGV131-LNP1265, A CRISPR/Cas9 Based Coagulation Factor IX Gene Insertion Therapy in Participants With Hemophilia B",
"has_exemption": false,
"start_date": "2024-09-11",
"completion_date": "2032-12-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05795140",
"publication_url": "https://clinicaltrials.gov/study/NCT05795140",
"title": "A Multi-center, Single Arm, Open-label Extension Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Iptacopan in Participants With Atypical Hemolytic Uremic Syndrome (aHUS) Who Have Completed a Preceding Iptacopan Phase 3 Study in aHUS",
"has_exemption": false,
"start_date": "2024-05-08",
"completion_date": "2032-12-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04877288",
"publication_url": "https://clinicaltrials.gov/study/NCT04877288",
"title": "A Prospective, Open-label, Multicenter, Randomized Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Renal Allograft Recipients Aged 12 to Less Than 18 Years of Age to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications",
"has_exemption": false,
"start_date": "2021-07-21",
"completion_date": "2032-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01306019",
"publication_url": "https://clinicaltrials.gov/study/NCT01306019",
"title": "Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency",
"has_exemption": false,
"start_date": "2012-09-25",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03520660",
"publication_url": "https://clinicaltrials.gov/study/NCT03520660",
"title": "Long-Term Follow-Up Of Subjects With CHC Who Achieved A Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents",
"has_exemption": false,
"start_date": "2018-10-19",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04423211",
"publication_url": "https://clinicaltrials.gov/study/NCT04423211",
"title": "Phase III Study of Local or Systemic Therapy INtensification DIrected by PET in Prostate CAncer Patients With Post-ProstaTEctomy Biochemical Recurrence (INDICATE)",
"has_exemption": false,
"start_date": "2020-10-08",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04880876",
"publication_url": "https://clinicaltrials.gov/study/NCT04880876",
"title": "A Phase 3, Long-term Safety Study of Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)",
"has_exemption": false,
"start_date": "2021-08-13",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04597359",
"publication_url": "https://clinicaltrials.gov/study/NCT04597359",
"title": "A Phase II Randomized Double Blinded Study of Green Tea Catechins (GTC) vs. Placebo in Men on Active Surveillance for Prostate Cancer: Modulation of Biological and Clinical Intermediate Biomarkers",
"has_exemption": false,
"start_date": "2021-10-05",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05659082",
"publication_url": "https://clinicaltrials.gov/study/NCT05659082",
"title": "Cognition and Magnetic Resonance Imaging After Psychiatric Neurosurgery for Intractable Obsessive-Compulsive Disorder- Phase 2",
"has_exemption": false,
"start_date": "2022-06-21",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Butler Hospital",
"sponsor_slug": "butler-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06019832",
"publication_url": "https://clinicaltrials.gov/study/NCT06019832",
"title": "Analysis of Varus Collapse in Obese Patients With Stem and Non-Stem Tibial Components Following Primary Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2023-08-14",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jacob M. Elkins",
"sponsor_slug": "jacob-m-elkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06714604",
"publication_url": "https://clinicaltrials.gov/study/NCT06714604",
"title": "Standard Versus Prolonged Neoadjuvant (Conversion) Chemotherapy to Prolong Survival of Patients With Borderline and Locally Advanced Pancreatic Cancer: a Phase III Randomized Controlled",
"has_exemption": false,
"start_date": "2023-10-18",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sahlgrenska University Hospital",
"sponsor_slug": "sahlgrenska-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05975593",
"publication_url": "https://clinicaltrials.gov/study/NCT05975593",
"title": "MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial (METEOR-CRATR)",
"has_exemption": false,
"start_date": "2024-01-11",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06325709",
"publication_url": "https://clinicaltrials.gov/study/NCT06325709",
"title": "Phase 1/2 Trial of Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-linked Chronic Granulomatous Disease",
"has_exemption": false,
"start_date": "2024-04-17",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06477939",
"publication_url": "https://clinicaltrials.gov/study/NCT06477939",
"title": "Phase III Randomized Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients to Evaluate Efficacy and Safety",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Institut de Cancerologie Strasbourg Europe",
"sponsor_slug": "institut-de-cancerologie-strasbourg-europe",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06849258",
"publication_url": "https://clinicaltrials.gov/study/NCT06849258",
"title": "A Prospective, Multicenter, Double Blind, Randomized, Clinical Study to Evaluate the Safety and Efficacy of The FloStent in Men Suffering From Benign Prostatic Hyperplasia Symptoms",
"has_exemption": false,
"start_date": "2025-02-10",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rivermark Medical",
"sponsor_slug": "rivermark-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07015853",
"publication_url": "https://clinicaltrials.gov/study/NCT07015853",
"title": "IIT2024-02-SHIAO-ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stephen Shiao",
"sponsor_slug": "stephen-shiao",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288203",
"publication_url": "https://clinicaltrials.gov/study/NCT07288203",
"title": "A Phase 2, Multicenter, Open-label Study of Lifileucel (Tumor-infiltrating Lymphocytes [TIL]) in Participants With Previously Treated Advanced Melanoma",
"has_exemption": false,
"start_date": "2025-11-28",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Iovance Biotherapeutics, Inc.",
"sponsor_slug": "iovance-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06008717",
"publication_url": "https://clinicaltrials.gov/study/NCT06008717",
"title": "A Prospective, Randomized Feasibility Clinical Trial Evaluating Bilateral Stimulation of the Dorsolateral Region of the Subthalamic Nucleus Receiving Hyperdirect (M1/SMA) Input in Subjects With Early-Stage Parkinson's Disease",
"has_exemption": false,
"start_date": "2028-01-01",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mallory Hacker",
"sponsor_slug": "mallory-hacker",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06010030",
"publication_url": "https://clinicaltrials.gov/study/NCT06010030",
"title": "A Randomized Clinical Trial of tDCS to Remediate Phonological Impairment in Aphasia",
"has_exemption": false,
"start_date": "2023-10-03",
"completion_date": "2033-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06052618",
"publication_url": "https://clinicaltrials.gov/study/NCT06052618",
"title": "Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)",
"has_exemption": false,
"start_date": "2025-03-17",
"completion_date": "2033-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06876142",
"publication_url": "https://clinicaltrials.gov/study/NCT06876142",
"title": "A Phase 1b/2 Study of Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma (RRMM)",
"has_exemption": false,
"start_date": "2026-03-24",
"completion_date": "2033-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07322263",
"publication_url": "https://clinicaltrials.gov/study/NCT07322263",
"title": "Intravesical Gemcitabine and Docetaxel for High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study (GEMDOCE-BU)",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2033-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Michael A. O'Donnell",
"sponsor_slug": "michael-a-odonnell",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07387926",
"publication_url": "https://clinicaltrials.gov/study/NCT07387926",
"title": "Open-label, Phase I/II Study to Evaluate Safety and Efficacy of Asciminib With Chemotherapy Followed by Asciminib Plus Blinatumomab in Pediatric, Adolescent, and Young Adults With Relapsed or Refractory BCR::ABL1-positive (Philadelphia Positive, Ph+) or BCR::ABL1-like (Ph-like) ALL",
"has_exemption": false,
"start_date": "2026-03-26",
"completion_date": "2033-01-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}